Compare Itama Ranoraya Tbk (IRRA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Itama Ranoraya Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Itama Ranoraya Tbk trades at Rp374 (market cap 598.4B, 375.6K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Itama Ranoraya Tbk is far larger — about 5.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| IRRA | SCPI | |
|---|---|---|
Market Cap | 598.4B | 104.4B |
Volume | 375.6K | — |
Lot | 3.76K | — |
Turnover | 139.49M | — |
Average Price | 371.39 | — |
Value | 139.49M | — |
Indicative Equilibrium Price | 374 | — |
Indicative Equilibrium Volume | 480 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Itama Ranoraya Tbk
PT. Itama Ranoraya Tbk ( theEntity) was established for the first time based on Deed of Establishment of Limited Liability Entity dated November 30, 1989 Number 116, made before Esther Daniar Iskandar, S.H., Notary in Jakarta. PT Global Dinamika Kencana is the majority shareholder of the Entity and also the Ultimate Parent Entity. The entity has started commercial operations at July 22, 2002.
Read more on IRRA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
